(TRVI) Trevi Therapeutics - Performance 122.9% in 12m
TRVI performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
18.67%
#52 in Peer-Group
Rel. Strength
95.08%
#380 in Stock-Universe
Total Return 12m
122.85%
#10 in Peer-Group
Total Return 5y
-14.76%
#87 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 7.06 USD |
| 52 Week Low | 2.49 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 30.94 |
| Buy/Sell Signal +-5 | 1.12 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: TRVI (122.9%) vs XLV (-3.8%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
3.97% | 137% | 332% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
5.14% | 18.3% | 78.4% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
3.98% | -12.5% | 396% | 63.3 | 35.6 | 1.19 | 58.2% | 18.9% |
| NOVN SW Novartis |
1.57% | 4.32% | 49.4% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-5.64% | 3.65% | 46.3% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-3.33% | -5.85% | 108% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-3.3% | -7.74% | 44% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
-1.26% | -7.68% | 38.7% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: TRVI vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for TRVI
| Total Return (including Dividends) | TRVI | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 0.00% | 2.34% | 5.22% |
| 3 Months | -4.34% | -4.88% | 16.86% |
| 12 Months | 122.85% | -3.83% | 14.81% |
| 5 Years | -14.76% | 42.89% | 111.83% |
| Trend Score (consistency of price movement) | TRVI | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -87.7% | 35.8% | 81% |
| 3 Months | -11.6% | -28.5% | 96.9% |
| 12 Months | 86.7% | -74.5% | 44.9% |
| 5 Years | 23.4% | 87.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th46.00 | -2.29% | -4.96% |
| 3 Month | %th32.00 | 0.57% | -18.14% |
| 12 Month | %th95.50 | 131.73% | 94.10% |
| 5 Years | %th55.50 | -40.34% | -59.76% |
FAQs
Does Trevi Therapeutics (TRVI) outperform the market?
Yes,
over the last 12 months TRVI made 122.85%, while its related Sector, the Health Care Sector SPDR (XLV) made -3.83%.
Over the last 3 months TRVI made -4.34%, while XLV made -4.88%.
Performance Comparison TRVI vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
TRVI vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.9% | -5.2% | 23.4% | 108% |
| US NASDAQ 100 | QQQ | 3.3% | -5.6% | 22.1% | 109% |
| German DAX 40 | DAX | 3.9% | 0.7% | 9.9% | 93% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 4.7% | -4.2% | 20.5% | 104% |
| Hongkong Hang Seng | HSI | 3.9% | -6.3% | 5% | 88% |
| India NIFTY 50 | INDA | 5% | -3.4% | 25.1% | 123% |
| Brasil Bovespa | EWZ | 0.9% | -8.3% | -3.4% | 111% |
TRVI vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.6% | -6.6% | 18.7% | 96% |
| Consumer Discretionary | XLY | 2.2% | -2.9% | 31.2% | 104% |
| Consumer Staples | XLP | 2.6% | 0.1% | 23.4% | 113% |
| Energy | XLE | 3.6% | -5% | 28.5% | 125% |
| Financial | XLF | 2.4% | -4.5% | 19.4% | 93% |
| Health Care | XLV | 4.2% | -2.3% | 31.3% | 127% |
| Industrial | XLI | 2.3% | -4.3% | 16.4% | 98% |
| Materials | XLB | 1% | -4.7% | 18.7% | 117% |
| Real Estate | XLRE | 3.1% | -1.3% | 25.7% | 110% |
| Technology | XLK | 2.8% | -8.9% | 20.3% | 111% |
| Utilities | XLU | 4.3% | -0% | 22% | 100% |
| Aerospace & Defense | XAR | 4.2% | -7.6% | 6.2% | 74% |
| Biotech | XBI | 3.3% | -3.5% | 37.4% | 129% |
| Homebuilder | XHB | 0% | -8.5% | 31.2% | 118% |
| Retail | XRT | -0.1% | -4.3% | 27.9% | 112% |
TRVI vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 3% | -7.58% | 33.1% | 130% |
| Natural Gas | UNG | 7.7% | 10.1% | 31.8% | 130% |
| Gold | GLD | 5% | 0.6% | 3.5% | 82% |
| Silver | SLV | 4.6% | -6.6% | 5.4% | 102% |
| Copper | CPER | 4.5% | -5% | 4.7% | 109% |
TRVI vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 5.9% | -2.7% | 27.8% | 124% |
| iShares High Yield Corp. Bond | HYG | 4.7% | -1.8% | 24.9% | 113% |